Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000404425 | SCV005619883 | benign | Mucopolysaccharidosis type 1 | 2024-12-06 | reviewed by expert panel | curation | The NM_000203.5:c.590-8C>T variant is a nucleotide substitution in the acceptor splice site region of intron 5 of IDUA. The highest population minor allele frequency in gnomAD v4.1.0 is 0.2984 (27112/90864 alleles; 4285 homozygotes; Grpmax Filtering AF 95% confidence = 0.2954) in the South Asian population, which is higher than the ClinGen Lysosomal Diseases VCEP’s threshold for BA1 (>0.005), and therefore meets this criterion (BA1). There is a ClinVar entry for this variant (Variation ID: 92646). In summary, this variant meets the criteria to be classified as benign for mucopolysaccharidosis type 1. IDUA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (Specifications Version 1.0.0): BA1. (Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on December 6, 2024) |
Eurofins Ntd Llc |
RCV000078396 | SCV000110242 | benign | not specified | 2017-11-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000078396 | SCV000302981 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000404425 | SCV000451773 | benign | Mucopolysaccharidosis type 1 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589331 | SCV000695974 | benign | not provided | 2016-01-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000404425 | SCV001730205 | benign | Mucopolysaccharidosis type 1 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001543820 | SCV001762690 | benign | Hurler syndrome | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001543821 | SCV001762691 | benign | Mucopolysaccharidosis, MPS-I-H/S | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001543822 | SCV001762692 | benign | Mucopolysaccharidosis, MPS-I-S | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000589331 | SCV001851983 | benign | not provided | 2018-07-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000589331 | SCV005306385 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000589331 | SCV000801299 | benign | not provided | 2016-02-02 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000078396 | SCV001742134 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000078396 | SCV001919603 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000078396 | SCV001976122 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000404425 | SCV002075297 | benign | Mucopolysaccharidosis type 1 | 2017-08-08 | no assertion criteria provided | clinical testing |